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Objective: The objective of this study was to document the impact of the
preoperative Karnofsky Performance Scale (KPS) and American Society of
Anesthesiologists (ASA) scores on perioperative complications in patients
with recurrent glioma who underwent tumor resection via craniotomy.
Methods: A total of 96 patients were retrospectively reviewed. Based on
KPS and ASA scores, patients were categorized into high KPS (> 70) or
low KPS (≤ 70) and high ASA (3~4) or low ASA (1~2) groups. Differences
in intraoperative risk factors and perioperative complications among the
groups were analyzed. Multivariate analysis was performed to identify
risk factors for perioperative complications.
Results: The most frequent perioperative complications were cerebrospinal
fluid leakage (31.8%) and intracranial infection (27.0%); 30-day mortality
was 5.2%. The incidence rates of severe complications, central nervous
system complications, and total complications were comparable in the low
and high KPS groups and in the low and high ASA groups (all p > 0.05).
Multivariate analysis showed that low KPS and high ASA scores were
not the independent risk factors for perioperative complications.
Conclusion: Low KPS and high ASA scores are not associated with
increased postoperative complications in patients with recurrent glioma
who undergo tumor resection via craniotomy.

© The authors 2019. This article
is published with open access at
http://jnr.tsinghuajournals.com
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1

Introduction

Glioma is the most common primary malignant
brain tumor, accounting for 24% of brain tumors
in adults [1]. The standard clinical treatment
for glioma includes maximal safe resection,

radiotherapy, and temozolomide chemotherapy.
However, glioma recurrence is inevitable due
to incomplete tumor resection and aggressive
invasion. Repeated craniotomy is one of the
common treatment strategies for patients with
recurrent glioma and has been shown to prolong
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postoperative survival, but it also increases the
incidence rates of perioperative complications
[2, 3]. Identifying preoperative risk factors could
be critical for patients with recurrent glioma.
Patient age; Karnofsky Performance Scale
(KPS); and tumor pathology, size, and location are
among the risk factors for increased postoperative
complications [4]. KPS is one of the widely
studied risk factors for predicting mortality and
morbidity in patients with glioma [4–8]. Increased
postsurgical complications in patients with glioma
with low KPS have been reported by several
groups [4, 9–11]. In addition, the American
Society of Anesthesiologists (ASA) score, which
is a widely used clinical preoperative physical
status classification, is a well-known risk factor
for preoperative mortality and complications
after craniotomy in patients with various brain
tumors [12–18]. However, little is known about
the impact of KPS and ASA scores in patients
who undergo craniotomy for recurrent glioma.
In the present study, we aimed to evaluate the
impact of KPS and ASA scores on perioperative
complications in patients with recurrent glioma
who undergo repeated craniotomy for glioma by
comparing the incidence of perioperative complications in patients with high versus low KPS
and with high versus low ASA scores.

Scientific Ethics Committee of the Xi’an Jiaotong
University.
Patients’ demographic characteristics, systemic
diseases (hypertension, cardiovascular disease,
lung disease, and diabetes mellitus), tumor
characteristics (pathological diagnosis and tumor
location and size), preoperative tumor-related
stroke status (defined as hemorrhagic or ischemic
stroke within the tumor area), pre- and postoperative laboratory blood test results (including
routine blood test and blood coagulation and liver
function tests), imaging (computed tomography
or magnetic resonance imaging findings), neurosurgical intensive care unit (NICU) stay duration,
KPS and perioperative complications were
recorded. The operation-associated intraoperative
risk factors (operation route, start and finish
time, amount of intraoperative blood loss, and
requirement of blood transfusion), extent of
resection (gross total resection, TR, 95%~100%
enhancement; subtotal resection, STR, 80%~95%
enhancement; partial resection, PR, < 80% enhancement), and ASA score were extracted from
operation and anesthesia records. The time of
skin incision was defined as the start time of the
procedure. All procedures were performed by
senior neurosurgeons with >10 years of neurosurgical experience.

2

2.2

2.1

Patients and methods
Patients

The medical records of patients who were
pathologically diagnosed with recurrent glioma
and underwent craniotomy at the First Affiliated
Hospital of the Xi’an Jiaotong University between
June 2008 and July 2014 were retrospectively
retrieved and analyzed. The pathological diagnosis
was determined by two senior neuropathologists
according to the 2016 World Health Organization
classification of central nervous system (CNS)
tumors [19]. The study was approved by and
conducted in accordance with the policies of the

Study design

Patients were excluded from the study if they
were <16 years old; if their medical records were
incomplete; or if they presented with uncontrolled
systemic disease, including abnormal blood
pressure and blood glucose levels (even with
medication), or with acute phase of cardiovascular or lung disease. Patients with a history of
glioma who had undergone craniotomy before
admission were included in the study. Data of
507 patients who had previously provided written
consent for their medical records to be used in
retrospective studies were retrieved, and 96 of
these patients were included in the study.
Journal of Neurorestoratology
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The KPS was recorded on the day of admission,
and the ASA scores was recorded on the day
before operation. On the basis of KPS and ASA
scores, patients were categorized into high KPS
(> 70) or low KPS (≤ 70) and high ASA (3~4) or
low ASA (1~2) groups.
Body mass index (BMI) was calculated using
preoperative height and weight. Prognostic
nutritional index (PNI) was calculated as follows:
PNI = 10 × serum albumin level (g/dL) + 0.005 ×
peripheral blood lymphocyte count.
Intraoperative medical events (blood loss,
blood transfusion, and operation duration) and
postoperative complications were considered
as perioperative complications. Postoperative
complications were subdivided into severe
complications, CNS complications, and systemic
complications. Severe complications were defined
as death within 30 days or unplanned reoperation
within 7 days of the operation. CNS complications
were defined as the occurrence of a seizure and
presence of a neurological deficit, an intracranial
infection, or cerebrospinal fluid (CSF) leakage.
Systemic complications included deep venous
thrombosis, electrolyte imbalance, systemic infections (pulmonary and urinary infections), and
other medical conditions arising postoperatively.
Neurological deficits that were newly diagnosed
after the repeated operation and not present
after the prior operation were considered as
complications of the repeated operation.
2.3

Statistical analysis

Numerical data were expressed as mean ±
standard deviation and compared between
two groups using Student’s t-test. Categorical
data were expressed as percentages and compared using chi-square test. Factors that were
reported to be of significant prognostic value in
the literature were included and analyzed in a
multivariate Cox proportional hazards model.
Statistical analyses were performed using SPSS
21.0 (Chicago, IL, USA). A p value < 0.05 was
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considered to be significant.

3

Results

A total of 550 craniotomies performed on 481
patients were retrospectively reviewed, and 96
patients were included in the present study.
In this cohort of patients, CSF leakage (31.8%)
and intracranial infection (27.0%) were the most
frequent perioperative complications. The overall
incidence of total complications was 60% (Table 1),
which was higher than that after the first craniotomy (data not shown). Notably, the incidence of
death within 30 days was 5.2% (Table 1), which
was comparable to that reported in the literature
[2, 3]. Baseline characteristics, stratified by KPS
and ASA scores, are summarized in Tables 2
and 3, respectively.
Table 1

Types of complications in 96 patients.
Complications

Incidence, n (%)

Extent of resection
GTR

79 (82.3)

STR

14 (14.5)

PR

3 (3.1)

Death within 30 days

5 (5.2)

Re-operation

1 (1.0)

Hemorrhage

4 (4.2)

Severe edema

3 (3.1)

Hydrocephalus

1 (1.0)

Neurological deficit

19 (19.8)

Intracranial infection

26 (27.0)

Seizure

13 (13.5)

Systemic infection

10 (10.4)

Pulmonary infection

9 (9.7)

Urinary infection

1 (1.0)

Venous thrombosis
CSF leak

0 (0)
21 (31.8)

Porencephalia

3 (3.1)

Severe complication

7 (7.3)

CNS complication

54 (56.3)

Systemic complication

10 (10.4)

Total complication

60 (62.5)
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Table 2

Clinical and pathological characteristics stratified

by KPS in 96 patients received repeated surgery.

Table 3

Clinical and pathological characteristics stratified

by ASA score in 96 patients received repeated surgery.

KPS ≤ 70
(n = 11)

KPS > 70
(n = 85)

p
value

Sex (male), n (%)

4 (36.4)

49 (57.6)

0.182

Sex (male), n (%)

Age (years)

45 ± 15

45 ± 10

0.032

Age (years)

21.3 ± 2.7

23.6 ± 3.1

0.897

Body mass index (kg/m2)

Variable

Body mass index (kg/m2)
Tumor stroke
Hemorrhagic stroke, n (%)

< 0.001

Variable

ASA = 1~2 ASA = 3~4
p
(n = 52)
(n = 44) value
33 (63.5)

20 (45.5)

0.077

46 ± 8

44 ± 12

0.020

23.3 ± 2.9

23.3 ± 3.5

0.451

Tumor stroke

0.019

6 (54.5)

2 (2.4)

Hemorrhagic stroke, n (%)

1 (1.9)

7 (15.9)

Ischemic stroke, n (%)

0 (0)

4 (4.7)

Ischemic stroke, n (%)

1 (1.9)

3 (6.8)

Hypertension, n (%）

2 (18.2)

7 (8.2)

0.287

Hypertension, n (%)

4 (7.7)

5 (11.4)

0.539

Diabetes Mellitus, n (%)

0 (0)

2 (2.4)

0.607

Diabetes Mellitus, n (%)

1 (1.9)

1 (2.3)

0.905

Cardiovascular Disease, n (%)

0 (0)

2 (2.4)

0.607

Cardiovascular Disease, n (%)

1 (1.9)

1 (2.3)

0.905

Chronic Lung Disease, n (%)

0 (0)

1 (1.2)

0.718

Chronic Lung Disease, n (%)

0 (0)

1 (2.3)

0.274

Smoking, n (%)

1 (9.1)

12 (14.1)

0.647

Smoking, n (%)

6 (11.5)

7 (15.9)

0.533

Drinking, n (%)

2 (18.2)

9 (10.6)

0.457

Drinking, n (%)

3 (5.8)

8 (18.2)

0.057

White blood cells (109/L)

8.7 ± 4.1

6.2 ± 2.9

0.019

White blood cells (109/L)

5.8 ± 1.9

7.3 ± 4.0

0.002

Platelet count (109/L)

162 ± 52

162 ± 45

0.570

Platelet count (109/L)

157 ± 44

170 ± 48

0.798

Hemoglobin (g/L)

13.0 ± 17.4

138.1 ±
17.7

0.695

Hemoglobin (g/L)

138 ± 15

138 ± 21

0.106

PT (s)

12.7 ± 0.8

12.5 ± 1.0

0.516

PT (s)

12.6 ± 1.0

12.4 ± 0.9

0.906

APTT (s)

31.8 ± 5.5

33.3 ± 4.8

0.679

APTT (s)

32.1 ± 3.7

34.4 ± 5.7

0.027

Albumin (g/L)

43.1 ± 5.9

41.0 ± 3.3

0.023

Albumin (g/L)

40.4 ± 3.1

42.3 ± 4.1

0.280

PNI

43.1 ± 5.9

41.0 ± 3.3

0.023

PNI

40.4 ± 3.1

42.3± 4.1

0.281

Tumor Size (cm)

5.5 ± 0.9

4.9 ± 1.6

0.352

Tumor Size (cm)

5.0 ± 1.5

5.0 ± 1.5

0.735

Tumor Location, n (%)

0.686

Tumor Location, n (%)

0.935

Frontal

3 (27.3)

35 (41.2)

Frontal

22 (42.3)

16 (36.4)

Temporal

3 (27.3)

14 (16.5)

Temporal

8 (15.4)

9 (20.5)

Parietal

0 (0)

6 (7.1)

Parietal

4 (7.7)

2 (4.5)

Occipital

0 (0)

2 (2.4)

Occipital

1 (1.9)

1 (2.3)

Thalamus

5 (45.5)

23 (27.1)

Thalamus

15 (28.8)

13 (29.5)

Multiple location

0 (0)

2 (2.4)

Multiple location

1 (1.9)

1 (2.3)

Infratentorial

0 (0)

3 (3.5)

Infratentorial

1 (1.9)

2 (4.5)

Tumor Grade, n (%)

0.760

Tumor Grade, n (%)

0.422

0 (0)

5 (5.9)

WHO Ⅰ

4 (7.7)

1 (2.3)

WHO Ⅱ

6 (54.5)

35 (41.2)

WHO Ⅱ

23 (44.2)

18 (40.9)

WHO Ⅲ

4 (36.4)

35 (41.2)

WHO Ⅲ

18 (34.6)

21 (47.7)

WHO Ⅳ

1 (9.1)

10 (11.8)

WHO Ⅳ

7 (13.5)

4 (9.1)

WHO I
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Eleven patients exhibited low KPS scores;
six of these patients were admitted with tumorrelated hemorrhagic stroke (Table 2). The incidence
of tumor-related stroke was higher in these
patients than in those with high KPS scores (p <
0.001). Despite some differences in albumin levels
and PNI, patients in the low and high KPS groups
had comparable BMI, systemic disease incidence,
and tumor characteristics (tumor location and
grade). Four patients underwent emergency tumor
resection because of tumor-related hemorrhagic
or ischemic stroke. The rate of emergency tumor
resection was higher in patients with low KPS
than in those with high KPS scores; however, the
incidence of various perioperative complications,
including death within 30 days, intracranial
infection, CSF leakage, and systemic infection,
was similar in both the groups (Table 4).
Table 4

Comparison of complications in patients received

repeated surgery classified by KPS.
Complications

KPS ≤ 70 KPS > 70
(n = 11) (n = 85)

p
value

(Continued)
KPS ≤ 70
(n = 11)

KPS > 70
(n = 85)

Venous thrombosis, n (%)

0 (0)

0 (0)

CSF leak, n (%)

1(9.1)

20 (23.5)

0.276

Porencephalia, n (%)

0 (0)

3 (3.1)

0.527

Severe complication, n (%)

0 (0)

7 (8.2)

0.323

CNS complication, n (%)

5 (45.5)

49 (57.6)

0.443

Systemic complication, n (%)

1 (9.1)

9 (10.6)

0.878

Total complication, n (%)

5 (45.5)

55 (64.7)

0.215

Complications

Table 5

p
value

Comparison of complications between ASA score

1~2 and 3~4.
Complications
Emergency surgery

ASA = 1~2 ASA = 3~4
p
(n = 52)
(n = 44) value
1 (1.9)

7 (15.9)

0.013

Operation Duration (h)

4.7 ± 1.8

4.4 ± 2

0.824

Blood-loss (mL)

545 ± 458

611 ± 409

0.990

Extent of resection, n (%)

0.041

GTR

47 (90.4)

32 (72.7)

STR

5 (9.6)

9 (20.5)

PR

0 (0)

3 (6.8)

Emergency surgery

4 (36.4)

4 (4.7)

< 0.001

NICU duration(days)

4±8

4±6

0.829

Operation Duration (h)

3.6 ± 1.0

4.6 ± 1.9

0.143

Death within 30 days

2 (3.8)

3 (6.8)

0.514

Blood-loss (mL)

639 ± 326 567 ± 448

0.590

Re-operation, n (%)

0 (0)

1 (2.3)

0.274

0.779

Extent of resection, n (%)

Hemorrhage, n (%)

1 (1.9)

3 (6.8)

0.232

GTR

9 (81.8)

70 (82.4)

Severe edema, n (%)

1 (1.9)

2 (4.5)

0.462

STR

2 (18.2)

12 (14.1)

Hydrocephalus, n (%)

0 (0)

1 (2.3)

0.274

PR

0 (0)

3 (3.5)

Neurological deficit, n (%)

9 (17.3)

10 (22.7)

0.507

NICU duration(days)

2±1

4±7

0.313

Intracranial infection, n (%)

15 (28.8)

11 (25.0)

0.673

Death within 30 days

0 (0)

5 (5.9)

0.409

Seizure, n (%)

6 (11.5)

7 (15.9)

0.533

Re-operation, n (%)

0 (0)

1 (1.2)

0.718

Systemic infection, n (%)

Hemorrhage, n (%)

0 (0)

4 (4.7)

0.462

Pulmonary infection, n (%)

Severe edema, n (%)

0 (0)

3 (3.5)

0.527

Hydrocephalus, n (%)

0 (0)

1 (1.2)

Neurological deficit, n (%)

3 (27.3)

Intracranial infection, n (%)
Seizure, n (%)

4 (7.7)

5 (11.4)

Urinary infection, n (%)

0 (0)

1 (2.3)

0.718

Venous thrombosis, n (%)

0 (0)

0 (0)

16 (18.8)

0.508

CSF leak, n (%)

11 (21.2)

10 (22.7)

0.853

4 (36.4)

22 (25.9)

0.462

Porencephalia, n (%)

0 (0)

3 (6.8)

0.056

2 (18.2)

11 (12.9)

0.633

Severe complication, n (%)

2 (3.8)

5 (11.4)

0.158

0.936

CNS complication, n (%)

29 (55.8)

25 (56.8)

0.918

4 (7.7)

6 (13.6)

0.342

32 (61.5)

28 (63.6)

0.832

Systemic infection, n (%)
Pulmonary infection, n (%)
Urinary infection, n (%)

0.445

1 (9.1)

8 (9.4)

Systemic complication, n (%)

0 (0)

1 (1.2)

Total complication, n (%)
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The rate of tumor-related stroke was significantly higher in patients with high ASA scores
than in those with low ASA scores (p = 0.019)
(Table 3); thus, the former underwent emergency
surgery and had a significantly lower extent of
tumor resection than the latter (p = 0.041) (Table 5).
Despite these differences, the incidence of perioperative complications was still comparable
between the two groups (Table 5).
Nonetheless, we found that low PNI was a
risk factor for total complications, which has not
been previously reported in patients undergoing
craniotomy. On multivariate analysis, neither
low KPS nor high ASA score was found to be
independently associated with a high incidence of
severe complications, CNS complications, or total
complications. Unexpectedly and interestingly,
the multivariate analysis in the present study
showed that women had a higher hazard rate of
CNS complications and total complications than
men (Table 6).
Table 6

4

Discussion

In the present study, we assessed the impact of
preoperative KPS and ASA scores on perioperative
complications in patients undergoing repeated
glioma resection. In contrast with the results
reported in the literature for patients with newly
diagnosed glioma undergoing primary craniotomy
[4, 9–11], we did not find any significant correlation between low KPS or high ASA score and
perioperative complications, including severe
complications (death within 30 days or unplanned
reoperation within 7 days), CNS complications,
and total complications.
Five patients (5.2%) died within 30 days of
the repeated operation; this rate is comparable
to that reported in previous studies (2.2%~16%)
[2, 3]. The most frequent complications were
CSF leakage and intracranial infection, and the
incidence of these complications was similar to

Multivariable analysis for severe complications, CNS complications and total complications after repeated surgery.
Severe complications
Variable

CNS complications

Total complications

Univariate analysis

p

Univariate analysis

p

Univariate analysis

p

HR (95% CI)

value

HR (95% CI)

value

HR (95% CI)

value

0.482 (0.043~5.331)

0.551

2.630 (0.948~7.292)

0.063

2.540 (0.851~7.584)

0.095

Age (≥ 65)

0.998

0.671 (0.041~10.852)

0.778

0.790 (0.047~13.288)

0.870

KPS (< 70)

0.998

1.878 (0.353~10.006)

0.460

Sex (Male)

0.217

ASA score (ASA 3~4)

0.221 (0.023~2.137)

0.192

1.112 (0.416~2.972)

0.833

1.112 (0.393~3.148)

0.842

BMI

0.858 (0.576~1.279)

0.452

1.057 (0.891~1.255)

0.522

0.996 (0.836~1.186)

0.965

PNI

1.159 (0.853~1.575)

0.346

1.088 (0.957~1.238)

0.197

1.175 (1.021~1.353)

0.025

Hypertension (Yes)

0.999

0.236 (0.029~1.899)

0.175

0.200 (0.022~1.854)

0.157

Diabetes (Yes)

0.999

0.999

0.999

Smoking (Yes)

0.541 (0.035~8.305)

0.660

1.686 (0.394~7.224)

0.481

1.540 (0.351~6.753)

0.567

Tumor size (≥ 5cm)

0.153 (0.015~1.532)

0.110

0.484 (0.176~1.331)

0.160

0.453 (0.154~1.338)

0.152

14.073 (0.650~332.616)

0.091

1.525 (0.110~21.228)

0.754

Tumor stoke (Yes)

0.998

3.020 (0.277~32.984)

0.365

3.848 (0.313~47.242)

0.292

Emergency (Yes)

0.998

0.848 (0.051~14.099)

0.909

1.033 (0.053~20.033)

0.983

Location (Supratentorial)

0.999
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that reported in previous studies (2.1%~35%)
[20, 21]. The surgical pathway for the repeated
operation was usually primary skin and skull
incisions and a similar or same pathway to
decrease damage, which was one of the risk factors
for wound-related complications, including CSF
leakage and intracranial infections [2].
In the literature, low KPS is one of the
established risk factors for perioperative complications in patients with glioma who undergo
craniotomy [4, 9–11]. However, most of these
studies focused on primary gliomas or gliomas
without clarification of recurrence status. The
present study did not find significant correlations
between perioperative complications and KPS
in this cohort of patients undergoing repeated
operation. This result is surprising and suggests
that repeated operation itself is an independent
risk factor for perioperative complications [2].
Increased risk of perioperative complications
has been reported in surgeries such as brain
tumor craniotomy [12–17]. Reportedly, the length
of hospital day after tumor resection is significantly longer in patients with high ASA scores
than in those with low ASA scores [12]. Reponen
et al. reported that high ASA scores are associated
with increased systemic and infectious complications [17]. A more recent study has confirmed
that high ASA scores are one of the independent
risk factors for surgical site infection after
craniotomy [18]. In the present study, the rate of
systemic infections was higher in the high ASA
than in the low ASA group, but the difference
was not significant. These results imply that
the impact of low KPS and high ASA scores on
perioperative complications is weaker than the
impact of repeated operation itself.
The present study is subject to several
limitations. First, it is a retrospective study with
its inherent limitations. As mentioned above,
the small study sample obtained from a single
center is another limitation, and it was difficult
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to include sufficient patients in the low KPS
group. In addition, KPS and ASA scores were
determined by multiple neurosurgeons and
anesthesiologists; thus, there is a possibility of
interobserver variability.
Notwithstanding these limitations, the present
study did not find a significant impact of KPS
and ASA scores on perioperative complications
in patients undergoing repeated craniotomy for
glioma. Further studies are needed to identify
the risk factors associated with repeated glioma
resection.
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